H Asita de Silva
Overview
Explore the profile of H Asita de Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang A, Hively A, Salam A, Prabhakaran D, de Silva H, Patel A, et al.
JACC Adv
. 2025 Jan;
3(12):101320.
PMID: 39817063
No abstract available.
2.
Ouyang M, Anjum A, Mc Cawley F, Wasay M, Ma L, Hu X, et al.
PLOS Glob Public Health
. 2024 Dec;
4(12):e0003711.
PMID: 39700102
The third, stepped-wedge, cluster-randomized, Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT3), has shown that a goal-directed multi-faceted Care Bundle incorporating protocols for the management...
3.
Rodgers A, Salam A, Schutte A, Cushman W, de Silva H, Di Tanna G, et al.
Lancet
. 2024 Oct;
404(10462):1536-1546.
PMID: 39426836
Background: Single-pill combinations (SPCs) of three low-dose antihypertensive drugs can improve hypertension control but are not widely available. A key issue for any combination product is the contribution of each...
4.
Rodgers A, Salam A, Schutte A, Cushman W, de Silva H, Di Tanna G, et al.
J Am Coll Cardiol
. 2024 Sep;
84(24):2393-2403.
PMID: 39217570
Background: Single-pill combinations of 3 or more low-dose blood pressure (BP)-lowering drugs hold promise for initial or early treatment of hypertension. Objectives: The authors conducted a placebo-controlled trial of a...
5.
Lee V, Monjur M, Santos J, Patel A, Liu R, Di Tanna G, et al.
J Diabetes
. 2024 Aug;
16(8):e13590.
PMID: 39136500
Background: While previously considered a transient condition, with no lasting adverse impact, gestational diabetes mellitus (GDM) is now a well-established risk factor for developing type 2 diabetes mellitus (T2DM). The...
6.
Bittner V, Schwartz G, Bhatt D, Chua T, de Silva H, Diaz R, et al.
J Clin Lipidol
. 2024 Jul;
18(4):e548-e561.
PMID: 38960812
Background: The ODYSSEY OUTCOMES trial (NCT01663402) compared the effects of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab with placebo on major adverse cardiovascular events (MACE) in patients with recent...
7.
Belsti Y, Moran L, Goldstein R, Mousa A, Cooray S, Baker S, et al.
Clin Nutr
. 2024 Jun;
43(8):1728-1735.
PMID: 38909514
Aims: This study aimed to develop a prediction model for identifying a woman with gestational diabetes mellitus (GDM) at high risk of type 2 diabetes (T2DM) post-birth. Methods: Utilising data...
8.
Gupta Y, Kapoor D, Lakshmi J, Praveen D, Santos J, Billot L, et al.
J Diabetes
. 2024 May;
16(5):e13559.
PMID: 38708437
Objectives: To explore associations between type and number of abnormal glucose values on antenatal oral glucose tolerance test (OGTT) with postpartum diabetes in South Asian women diagnosed with gestational diabetes...
9.
Zhu A, Ostbye T, Naheed A, de Silva H, Jehan I, Gandhi M, et al.
J Clin Hypertens (Greenwich)
. 2024 Mar;
26(4):391-404.
PMID: 38450866
Hypertension is a leading risk factor for cardiovascular disease in South Asia. The authors aimed to assess the cross-country differences in 24-h ambulatory, daytime, and nighttime systolic blood pressure (SBP)...
10.
Fernando M, Silva R, Fernando W, de Silva H, Wickremasinghe A, Dissanayake A, et al.
J Alzheimers Dis
. 2023 Nov;
96(3):1195-1206.
PMID: 37980665
Background: Virgin coconut oil (VCO) is a potential therapeutic approach to improve cognition in Alzheimer's disease (AD) due to its properties as a ketogenic agent and antioxidative characteristics. Objective: This...